Employment Data Summary - In July 2025, the U.S. non-farm payrolls increased by 73,000, significantly below the expected 104,000, with the previous month's figure revised down from 147,000 to 14,000, resulting in a total downward revision of 253,000 for May and June[2] - The unemployment rate rose from 4.1% to 4.2%, while the U6 unemployment rate increased by 0.2 percentage points to 7.9%[2] - The labor force participation rate fell for the fourth consecutive month, decreasing by 0.1 percentage points to 62.2%[2] Wage Growth Insights - Private sector hourly wage growth increased from 0.2% to 0.3% month-on-month, driven primarily by the service sector, where wage growth rose from 0.2% to 0.4%[3] - Retail sector hourly wage growth surged from 0.2% to 1.2%, attributed to increased hiring demand during the summer season and inventory replenishment[3] Sector Performance Analysis - The service sector added 96,000 jobs in July, while the production sector remained weak, with a loss of 13,000 jobs[2] - Government employment decreased by 10,000, with federal government layoffs continuing[2] Market Reactions and Future Outlook - Following the release of the employment data, market expectations for a rate cut increased, with the probability of a 25 basis point cut in September rising from 43.2% to 80.3%[3] - The report indicates a growing concern over the dual challenge of "low employment" and "high inflation," complicating the Federal Reserve's policy decisions[3]

Group 1 - The report highlights a rebound in prices with structural differentiation in the domestic market, as indicated by the July PMI data, where the manufacturing PMI slightly decreased to 49.3% from 49.7%, and the non-manufacturing PMI fell to 50.1% from 50.5% [5][6] - The report notes that the July PMI reflects the impact of trade easing and seasonal factors, with a significant characteristic being the rise in upstream prices and a counter-trend increase in high-energy-consuming industries' PMI, suggesting effects from the "anti-involution" initiative [5][6] - The manufacturing PMI's slight decline is attributed to the seasonal downturn and the impact of tariff easing, with the new orders index dropping to 49.4% and the new export orders index at 47.1%, indicating weakening demand [6][7] Group 2 - The report discusses the July FOMC meeting, where the Federal Reserve maintained the benchmark interest rate at 4.25%-4.50%, reflecting internal divisions among officials regarding the employment market, with some expressing concerns over its cooling [11][12] - The FOMC statement indicated heightened uncertainty in economic prospects, with a shift from describing economic growth as "solid" to "moderated," highlighting concerns over consumer spending's impact on growth [12][13] - The report emphasizes the importance of upcoming non-farm employment data in guiding market expectations, as the employment market is nearing pre-pandemic levels, with the ratio of job vacancies to unemployment at 1.39 in June 2025 [13][14] Group 3 - The report analyzes the U.S. GDP data for Q2 2025, which showed a strong performance with a 3.0% annualized growth rate, driven by personal consumption and trade, while private investment turned negative [16][17] - The net export contribution to GDP improved due to a significant drop in imports, while exports were negatively impacted by trade protection policies, leading to a decline in export growth [17][18] - Personal consumption rebounded in Q2, with a growth rate of 1.4%, supported by improved consumer confidence and a shift towards "passive de-inventory" in the goods market [18][19] Group 4 - The report includes key economic news, such as the State Council's meeting on July 31, emphasizing the importance of enhancing macro policy effectiveness and stimulating economic growth through various measures [22][23] - The National Development and Reform Commission's meeting highlighted the need to stabilize employment and market expectations while promoting domestic and international dual circulation [24][25] - The Bank of Japan maintained its benchmark interest rate at 0.5% and raised its core CPI forecasts for the fiscal years 2025-2027, indicating a cautious outlook on inflation [28]

Economic Performance - The U.S. GDP for Q2 2025 showed a quarter-on-quarter annualized growth rate of 3.0%, exceeding the expected 2.4% and rebounding from a previous decline of -0.5% in Q1[2] - Year-on-year GDP growth remained stable at 2.0%, consistent with the previous quarter[2] Consumption and Trade - Personal consumption increased from a previous annualized rate of 0.5% in Q1 to 1.4% in Q2, contributing 1.0 percentage points to GDP growth[2] - Net exports improved significantly due to a sharp decline in imports, which fell from an annualized rate of 37.9% to -30.3%, raising the contribution to GDP from -4.6% to 5.0%[2] Investment Trends - Private investment saw a dramatic decline, with an annualized rate dropping from 23.8% in Q1 to -15.6% in Q2, negatively impacting GDP by 3.1 percentage points[2] - Residential investment continued to decline, with an annualized rate of -4.6% in Q2, reflecting ongoing pressures from high mortgage rates and immigration policies[2] Government Spending - Government spending rebounded to an annualized growth rate of 0.4% in Q2, driven primarily by increased defense spending and state/local government hiring[2] - State and local government expenditures rose from 2.0% in Q1 to 3.0% in Q2, indicating a positive trend in public sector investment[2] Market Reactions - Following the GDP release, market expectations for interest rate cuts diminished, leading to an increase in the U.S. dollar index and bond yields, while gold prices fell[2] - The Michigan Consumer Sentiment Index improved, reaching 61.8 in July, indicating a recovery in consumer confidence[2]

Key Insights - The report emphasizes the importance of enhancing quality and efficiency in the current economic environment, with a focus on stabilizing policies and timely support to navigate uncertainties [5][6][7] - The upcoming 14th National Congress will address the 15th Five-Year Plan, highlighting the need for strategic breakthroughs in modernization and economic development [6][7] - The report notes a positive outlook for domestic demand, particularly in service consumption, and suggests that investment policies will aim to invigorate private investment [8][9] Group 1: Domestic Economic Observations - The Central Political Bureau's meeting on July 30, 2025, indicated a GDP growth rate of 5.3% in the first half of the year, suggesting a lower difficulty in achieving the annual growth target of 5% [5][6] - The meeting emphasized the need for continuous and stable policies while maintaining flexibility to respond to uncertainties, particularly in the context of external economic pressures [7][8] - The report highlights the importance of optimizing competition order and addressing issues of "involution" in the market, which could lead to a long-term recovery in price levels [9][10] Group 2: Financial Sector Developments - The report discusses the planned H-share listing of First Capital Securities, which aims to enhance its capital strength and international competitiveness [11][12] - The insurance sector is experiencing a downward adjustment in preset interest rates, with significant implications for the sales of dividend insurance products [13][14] - The report suggests that the financial market is witnessing a trend towards internationalization, with securities firms expanding their service offerings beyond traditional roles [12][14] Group 3: Market Performance and Data - The non-bank financial index rose by 3.5%, outperforming the Shanghai and Shenzhen 300 indices, indicating a positive market sentiment [11] - The report provides detailed market data, including a daily average trading volume of 22,338 billion yuan, reflecting a 19.4% increase week-on-week [11][28] - The A-share market showed mixed performance, with the Shanghai Composite Index closing at 3,615 points, a slight increase of 0.17%, while the ChiNext Index fell by 1.62% [21][22]

Group 1 - The report highlights that Shouchao Securities plans to list H shares, indicating a window for interest rate reduction, which is expected to enhance the company's capital strength and competitiveness in the international market [5][6] - The non-bank financial sector index rose by 3.5%, outperforming the CSI 300 by 1.8 percentage points, with brokerage and insurance indices also showing synchronized increases of 4.8% and 1.8% respectively [5][6] - The report notes a significant increase in the average daily trading volume of the stock market to 22,338 billion yuan, a week-on-week increase of 19.4%, alongside a 2.4% increase in margin trading balance [5] Group 2 - The report indicates that the preset interest rate for life insurance products has been adjusted down to 1.99%, a decrease of 14 basis points from the previous quarter, prompting several major insurance companies to lower their rates for various insurance products [7] - The adjustment in interest rates is expected to enhance the competitiveness of dividend insurance products, aligning with regulatory guidance to support their sales [7] - The report emphasizes that despite the downward adjustment, the attractiveness of insurance products remains, particularly in the context of declining interest rates in other financial products [7] Group 3 - The IMF has raised its economic growth forecast for China in 2025 to 4.8%, an increase of 0.8 percentage points from previous estimates, reflecting stronger-than-expected economic activity in the first half of the year [14][15] - The report mentions that the ongoing US-China trade talks in Stockholm are aimed at stabilizing economic relations and addressing mutual concerns, which could further influence economic conditions [15][16] Group 4 - The report provides an analysis of the A-share market, noting that the Shanghai Composite Index closed up by 0.33% at 3,609 points, with significant net outflows of large funds totaling over 123 billion yuan [17][18] - The healthcare services sector showed the highest increase among industry sectors, rising by 5.38%, while the aquaculture sector experienced a decline of 1.81% [22] - The report highlights that the market is approaching key resistance levels, necessitating close monitoring of volume and price indicators [18][19]

Investment Rating - The industry investment rating is "Overweight" for the non-bank financial sector, indicating a positive outlook compared to the broader market [1][36]. Core Insights - The non-bank financial index increased by 3.5% last week, outperforming the CSI 300 by 1.8 percentage points, with significant gains in both brokerage and insurance indices [4][8]. - The average daily trading volume for stock funds reached 22,338 billion yuan, a week-on-week increase of 19.4% [17]. - The scheduled interest rate for life insurance products has been adjusted down to 1.99%, which is expected to influence the sales rhythm of dividend insurance [4][34]. Summary by Sections Market Review - The non-bank financial index rose by 3.5%, with the brokerage index up by 4.8% and the insurance index up by 1.8% [4][8]. - The average daily trading volume for stock funds was 22,338 billion yuan, reflecting a 19.4% increase from the previous week [17]. Brokerage Insights - The announcement of H-share listing by First Capital Securities aims to enhance capital strength and international competitiveness [4]. - The brokerage sector is experiencing a trend towards internationalization, with increased capital injections and a broader range of services beyond traditional offerings [4]. Insurance Insights - The scheduled interest rate for life insurance products has been reduced to 1.99%, with major insurers adjusting their product rates accordingly [4]. - The adjustments are expected to enhance the competitiveness of dividend insurance products, aligning with regulatory support for their sales [4]. Investment Recommendations - For brokerages, it is advised to focus on opportunities in mergers and acquisitions, wealth management transformation, and innovative licensing [4]. - For insurance companies, attention should be given to large comprehensive insurers with competitive advantages under the new regulatory framework [4].

Group 1 - The report highlights a narrowing decline in industrial profits in June 2025, with a year-on-year decrease of -1.8%, an improvement from -1.1% in the previous month, driven by a recovery in industrial production due to eased US-China trade relations [6][8] - The automotive manufacturing sector showed a significant profit growth, with profits rising from -27% to 97% year-on-year, contributing positively to overall industrial profits [8][7] - The report notes a seasonal profit increase of 18.7% in June, surpassing the five-year average of 8.7%, indicating a stronger-than-seasonal performance [6][7] Group 2 - The insurance industry has seen a downward adjustment in the preset interest rate to 1.99%, a decrease of 14 basis points from the previous quarter, influenced by a continuous decline in market interest rates [11][12] - Major insurance companies have announced adjustments to their traditional life insurance products, reducing preset interest rates from 2.5% to 2.0%, and dividend-type products from 2% to 1.75% [12][13] - The report emphasizes that the non-symmetric adjustment of interest rates enhances the competitiveness of dividend insurance products, aligning with regulatory support for their sales [13][14] Group 3 - Google's Q2 2025 revenue increased by 14% year-on-year, with cloud revenue reaching $13.6 billion, a 32% increase, and annualized revenue surpassing $50 billion [16][17] - The report indicates that Google's capital expenditure for the year has been raised by $10 billion to $85 billion, primarily for server procurement and data center construction [17] - The World Artificial Intelligence Conference (WAIC) 2025 showcased significant AI innovations, indicating a robust growth trajectory for the electronic industry driven by AI and cloud services [18][19] Group 4 - The food and beverage sector experienced a slight increase of 0.74% in the market, with pre-processed foods and health products performing relatively well [21][22] - The report notes that the white wine sector is seeing a rebound due to favorable policies, despite a significant reduction in fund allocations to the sector by public funds [22][26] - The beer sector is expected to recover gradually, with low inventory levels and improving cost structures [23][24] Group 5 - The agricultural chemical industry is expected to recover due to the implementation of a three-year action plan aimed at addressing issues such as illegal production and unfair competition [28][29] - The report highlights that the basic chemical industry has shown a strong performance, with the basic chemical index rising by 4.03%, outperforming the broader market [29][30] - The report suggests that the supply-side reforms will lead to structural optimization in the agricultural chemical sector, with potential price recovery [31][32] Group 6 - The medical device sector is stabilizing, with a 1.90% increase in the medical and biological sector, outperforming the broader market [33][36] - Recent government initiatives to support innovative drugs and medical devices are expected to enhance the growth prospects of the medical device industry [35][36] - The report recommends focusing on high-quality stocks in the medical device sector, particularly those involved in innovative drugs and medical services [36]

Investment Rating - The report assigns an "Overweight" rating to the food and beverage industry, indicating that the industry index is expected to outperform the CSI 300 index by 10% or more over the next six months [1]. Core Insights - The food and beverage sector saw a 0.74% increase last week, underperforming the CSI 300 index by 0.95 percentage points, ranking 26th among 31 first-level sectors [12]. - The report highlights a rebound opportunity in the liquor sector, particularly for high-end and regional leading brands, as market sentiment improves and policy catalysts emerge [7][12]. - The beer sector is expected to recover this year, despite short-term disruptions from delivery platforms, with low inventory levels and favorable cost trends [7][12]. - The snack segment shows high growth potential, driven by strong categories and new channels, with specific products like konjac gaining popularity [7][12]. - The report emphasizes the importance of monitoring the dairy sector, where prices are stabilizing, and a potential turning point in raw milk prices is anticipated [7][12]. Summary by Sections 1. Market Performance - The food and beverage sector's performance last week was characterized by a 0.74% increase, with pre-processed foods and health products performing relatively well, rising by 1.97% and 1.88% respectively [12][17]. - The top five gainers included *ST Xifa, Jiaoda Anli, Huang Shang Huang, Tianyou Dejiu, and Tianrun Dairy, with increases ranging from 5.92% to 9.89% [12][17]. 2. Price Trends - As of July 27, 2024, the batch price for 2024 Moutai (scattered) was 1900 yuan, reflecting a weekly increase of 10 yuan and a monthly increase of 50 yuan [21]. - The beer production for June 2025 was reported at 4.12 million kiloliters, showing a year-on-year decrease of 0.2% [26]. 3. Industry Dynamics - The beverage manufacturing sector's profit decreased by 2.1% year-on-year in the first half of 2025, with total revenue reaching 814.69 billion yuan, a 1.9% increase [53]. - Jiangsu province's liquor production in the first half of 2025 was 81,700 kiloliters, down 15% year-on-year [53]. 4. Company Updates - Yanjing Beer announced a cash dividend of 1.90 yuan per 10 shares, totaling 536 million yuan, with the record date set for July 28 [55]. - Jiu Gui Jiu declared a cash dividend of 6.00 yuan per 10 shares, amounting to 195 million yuan, with the record date on July 30 [55].

Investment Rating - The report rates the industry as "Overweight" [1] Core Insights - Supply-side policies are expected to accelerate, focusing on sectors with supply elasticity in the basic chemical industry. The domestic policy emphasizes supply-side reforms, while international raw material costs are rising, leading to capacity exits in European and American chemical companies. In the long term, China's chemical industry has a competitive advantage due to cost and technological advancements, which may reshape the global chemical industry landscape [6][17]. Summary by Sections 1. Industry News and Event Commentary - The "Three-Year Action Plan for Rectifying the Pesticide Industry" was launched, aiming to improve market order and product quality by addressing issues like illegal production and unfair competition. The goal is to enhance compliance awareness among enterprises and optimize the supply structure in the pesticide industry by the end of 2027 [14]. 2. Chemical Sector Weekly Performance - The CSI 300 index rose by 1.69%, while the Shenwan Basic Chemical Index increased by 4.03%, outperforming the market by 2.34 percentage points. The Shenwan Oil and Petrochemical Index rose by 2.58%, also outperforming the market [19][22]. 3. Key Sub-industry Investment Recommendations - Focus on sectors with structural supply optimization, such as organic silicon, membrane materials, chlorine-alkali, and dyes. Key companies to watch include Hesheng Silicon Industry, Xingfa Group, Dongcai Technology, Zhejiang Longsheng, and Runtu Co. Additionally, for sectors with relatively weak supply-demand dynamics, attention should be on leading companies like Baofeng Energy, Juhua Co., Yangnong Chemical, Guangxin Co., and Runfeng Co. [6][18]. 4. Price Data Tracking - Notable price increases for the week included TDI (East China) at 15.58%, organic silicon DMC at 8.45%, and vitamin E at 6.06%. Conversely, hydrochloric acid saw a significant drop of 56.52% [29][30]. 5. Market Trends and Consumer Demand - New consumer trends are driving demand for health additives and sugar substitutes, with regulatory policies promoting the expansion of the food additive industry. Companies focusing on technology and product differentiation, such as Bailong Chuangyuan and Jinhai Technology, are expected to benefit [7][18]. 6. Industry Data Tracking - The report highlights that the overall self-sufficiency rate of new chemical materials in China is approximately 56%, indicating a significant opportunity for domestic substitution and development in various sectors, including semiconductor materials and high-end engineering plastics [7][18].

Investment Rating - The report assigns an "Overweight" rating to the pharmaceutical and biotechnology industry, indicating that the industry index is expected to outperform the CSI 300 index by 10% or more over the next six months [2][40]. Core Insights - The pharmaceutical and biotechnology sector saw an overall increase of 1.90% from July 21 to July 25, 2025, ranking 19th among 31 industries in the Shenwan index, outperforming the CSI 300 index by 0.21 percentage points [4][12]. - The current PE valuation of the pharmaceutical and biotechnology sector is 30.67 times, which is at the historical median level, with a valuation premium of 140% compared to the CSI 300 index [4][18]. - The top three performing sub-sectors during the same period were medical services (6.73%), medical devices (4.43%), and pharmaceutical commerce (1.84%) [4][12]. Market Performance - In the year-to-date, the pharmaceutical and biotechnology sector has increased by 18.81%, ranking 3rd among 31 industries, and outperforming the CSI 300 index by 13.92 percentage points [4][13]. - The sub-sectors that achieved significant gains include chemical pharmaceuticals (34.25%), medical services (32.34%), and biological products (13.49%) [4][19]. Industry News - The National Healthcare Security Administration (NHSA) held two meetings to support the high-quality development of innovative drugs and medical devices, emphasizing the need for comprehensive value assessments for innovative products [5][34]. - The NHSA introduced new measures to empower innovation in drug and device pricing, aiming to support genuine innovation and improve the quality of healthcare in China [5][36]. Investment Recommendations - The report suggests focusing on high-quality stocks in the following segments: innovative drugs, CXO (Contract Research Organization), chain pharmacies, medical services, and second-class vaccines [5][37][38]. - Recommended stocks include Betta Pharmaceuticals, Teva Biopharmaceuticals, Kaili Medical, Haier Biomedical, Huaxia Eye Hospital, and Lao Bai Xing [5][38]. Stock Performance - During the last week, 337 stocks in the sector increased in value (71.10%), while 127 stocks decreased (26.79%). The top five gainers were Haitai Biological (46.93%), Zhendong Pharmaceutical (42.89%), Saili Medical (31.73%), Chenxin Pharmaceutical (30.75%), and Rendu Biological (27.82%) [4][27].